Importance of minimal residual disease testing during the second year of therapy for children with acute lymphoblastic leukemia

No Thumbnail Available
Date
2003
Authors
Waters, Keith
Webster, Boyd
Zhu, Ling
Sykes, Pamela Joy
Morley, Alexander Alan
Brisco, Michael
Xue, Chengyuan
Dalla Pozza, Luciano
Ferrara, Daniella
Haber, Michelle
Journal Title
Journal ISSN
Volume Title
Publisher
Rights
Rights Holder
Abstract
Description
Keywords
Citation
Marshall, G.M., Haber, M., Kwan, E., Zhu, L., Ferrara, D., Chengyuan, X., Brisco, M., Sykes, P.J., Morley, A.A., Webster, et al., 2003. Importance of minimal residual disease testing during the second year of therapy for children with acute lymphoblastic leukemia. Journal of Clinical Oncology, 21(4), 704-709.